Bile is a reliable and valuable source to study cfDNA in biliary tract cancers
ObjectiveThe aim of this study is to determine the clinical efficacy of bile-derived liquid biopsy compared with plasma and tumor tissue biopsy in patients with biliary tract carcinoma (BTC).MethodsA total of 13 patients with BTC were enrolled in this cohort. Tumor tissue, bile, and plasma samples w...
Main Authors: | Zhanghui Li, Yelei Liu, Junhui Fu, Joseph Mugaanyi, Junrong Yan, Caide Lu, Jing Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.961939/full |
Similar Items
-
Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers
by: Yun-cheng Li, et al.
Published: (2022-10-01) -
Liquid biopsy in biliary tract cancer from blood and bile samples: current knowledge and future perspectives
by: Gianluca Arrichiello, et al.
Published: (2022-06-01) -
Epidemiological, clinical and microbiological characteristics of patients with biliary tract diseases with positive bile culture in a tertiary hospital
by: Tingting Liu, et al.
Published: (2024-09-01) -
Molecular diagnosis of pancreatobiliary tract cancer by detecting mutations and methylation changes in bile samplesResearch in context
by: Shun He, et al.
Published: (2023-01-01) -
Bile Acids and Biliary Fibrosis
by: Sayed Obaidullah Aseem, et al.
Published: (2023-03-01)